Gitelman综合征的临床特征、症状与长期结局
该研究通过欧洲医生调查和荷兰患者调查,纳入13个国家587例Gitelman综合征患者(25%为儿童),93%完成基因分型,94%存在SLC12A3变异。患者存在电解质紊乱、血磷降低、症状负担重及软骨钙化、血细胞计数升高、白蛋白尿或蛋白尿比例较高等特点,而CKD和高血压患病率低于一般人群。
要点
- Gitelman综合征患者血镁与血钾、血钾与醛固酮呈正相关,血磷显著降低。
- 成人女性及血镁较低者症状负担更高,盐渴和烦渴多尿为最严重症状。
- 治疗以补钾(94%)和补镁(50%)为主,保钾药物(33%)仅轻微升高血钾。
核心结论
- Gitelman综合征患者存在明确的电解质紊乱、症状负担和长期并发症,CKD和高血压患病率低于一般人群但白蛋白尿或蛋白尿比例较高。
研究设计与样本
- 对欧洲Gitelman综合征医生和荷兰患者进行问卷调查,共纳入13个国家587例患者(25%为儿童),并与一般人群比较。
主要发现
- 93%患者完成基因分型,94%存在SLC12A3变异。
- 儿童患者身高和体重低于一般人群,低体重持续至成年。
- 性别分布不均,儿童期男性多,成年期女性多。
- 血镁与血钾、血钾与醛固酮呈正相关,血磷显著降低。
- 成人患者软骨钙化患病率15%,血细胞计数升高者占26%。
关键数值与推荐
- 补钾治疗占94%,补镁治疗占50%,保钾药物占33%。
- 保钾药物使血钾轻微升高(3.2 vs. 3.1 mmol/l)。
临床怎么用
- 应关注Gitelman综合征患者的电解质紊乱、症状负担及长期并发症,治疗以补钾和补镁为主。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Gitelman syndrome (GS) is a rare inherited salt-losing tubulopathy with limited clinical data. METHODS: Surveys were conducted with GS physicians in Europe and patients with GS in the Netherlands to compare findings with the general population. RESULTS: Data from 587 patients (25% pediatric) across 13 countries showed 93% were genotyped, with 94% having variants in SLC12A3. Children with GS were shorter and lighter than the general population, with lower bodyweight persisting into adulthood. The sex distribution was uneven, with more males in childhood and more females in adulthood. Patients with GS had the expected electrolyte disorders as well as significantly lower blood phosphate levels. Positive correlations were found between blood magnesium and potassium, and potassium and aldosterone. Physicians reported muscle cramps, salt craving, and muscle weakness as most common GS symptoms. Patients with GS scored worse than the general population in fatigue, physical, and cognitive function; and ranked salt craving and polydipsia-polyuria as the most severe symptoms. Symptom burden was higher in adult females and patients with lower blood magnesium. Treatment mainly consisted of potassium (94%) and magnesium (50%) supplementation. Potassium-sparing medication (used in 33%) slightly increased blood potassium levels (3.2 vs. 3.1 mmol/l). Adult patients with GS had a high prevalence of chondrocalcinosis (15%) and elevated blood cell counts (26%). Compared with the general population, adult patients with GS had lower rates of chronic kidney disease (CKD) and hypertension, a similar rate of diabetes, but a higher rate of albuminuria or proteinuria (28%). CONCLUSIONS: These findings provide new insights into GS, highlight disease burden, and suggest areas for future research.
引用
- Wieërs MLAJ, Allard L, D'Ambrosio V, et al. Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman Syndrome. Kidney Int Rep. 2025. PMID: 41278357. doi:10.1016/j.ekir.2025.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。